Advertisement
Screener

CASI PHARMACEUTICALS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

CASI PHARMACEUTICALS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

CASI PHARMACEUTICALS, INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $19.89 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2019-03-29

  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-12-31 was $7.23K, a 205.41% increase year-over-year.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-09-30 was $16.11K.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-06-30 was -$10.32K, a 283.16% decline year-over-year.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-03-31 was $6.87K, a 289.24% increase year-over-year.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2017 was $19.89K, a 193.03% increase from fiscal 2016.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2016 was $6.79K.
  • CASI PHARMACEUTICALS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2015 was -$27.51K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month
2017-12-31$7.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$23.34K
derived: sum of 2 quarters · filed 2019-03-29
$13.02K
derived: sum of 3 quarters · filed 2019-03-29
$19.89K
10-K · filed 2019-03-29
2017-09-30$16.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$5.79K
derived: sum of 2 quarters · filed 2017-11-14
$12.66K
10-Q · filed 2017-11-14
$15.03K
derived: sum of 4 quarters · filed 2018-03-29
2017-06-30-$10.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$3.44K
10-Q · filed 2017-08-14
-$1.08K
derived: sum of 3 quarters · filed 2018-03-29
-$4.06K
derived: sum of 4 quarters · filed 2018-03-29
2017-03-31$6.87K
10-Q · filed 2017-05-15
$9.24K
derived: sum of 2 quarters · filed 2018-03-29
$6.26K
derived: sum of 3 quarters · filed 2018-03-29
$11.90K
derived: sum of 4 quarters · filed 2018-03-29
2016-12-31$2.37K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
-$612.00
derived: sum of 2 quarters · filed 2018-03-29
$5.02K
derived: sum of 3 quarters · filed 2018-03-29
$6.79K
10-K · filed 2018-03-29
2016-09-30-$2.98K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$2.66K
derived: sum of 2 quarters · filed 2016-11-14
$4.42K
10-Q · filed 2016-11-14
-$5.75K
derived: sum of 4 quarters · filed 2016-11-14
2016-06-30$5.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$7.40K
10-Q · filed 2016-08-15
-$2.77K
derived: sum of 3 quarters · filed 2016-08-15
-$38.46K
derived: sum of 4 quarters · filed 2016-08-15
2016-03-31$1.77K
10-Q · filed 2016-05-13
-$8.40K
derived: sum of 2 quarters · filed 2016-05-13
-$44.09K
derived: sum of 3 quarters · filed 2016-05-13
2015-12-31-$10.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
-$45.86K
derived: sum of 2 quarters · filed 2016-03-28
-$27.51K
10-K · filed 2016-03-28
2015-09-30-$35.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
-$17.35K
10-Q · filed 2015-11-13
2015-06-30$18.34K
10-Q · filed 2015-08-14